Class III — Theralase Inc.
| Recalling firm | THERALASE INC. |
|---|---|
| Registered facility | Theralase Technologies Inc. (the firm's only registered facility) |
| Classification | Class III |
| Status | Terminated |
| Reason | 905 nm laser diodes may be below rated power output. |
| Product | TLC-2000 Therapeutic Medical Laser System |
| Quantity | 92 units |
| Distribution | USA; Australia, Bahrain, Canada, Hong Kong Province of China, Jordan, Mexico, Pakistan, Philippines, Thailand, Romania |
| Initiated | 2019-09-26 |
| Classified | 2020-02-24 |
| Terminated | 2020-06-04 |
| Recall number | Z-1354-2020 |
| Initiation | Voluntary: Firm initiated |
Source: U.S. FDA via openFDA (opens in a new tab) (device registration & enforcement). Data as of 2026-10-06. Verify this recall record at FDA → (opens in a new tab)
Cite this record
RegWarden. “Class III recall — Theralase Inc. (Z-1354-2020).” Compiled from U.S. FDA public records (openFDA; FDA Data Dashboard). Data as of 2026-10-06. https://regwarden.com/recall/84843/
Alerts for THERALASE INC.
Watchlist alerts will email you when FDA publishes a new recall, inspection classification, or warning letter for a facility you follow. They aren't open to the public yet — leave your email and we'll tell you when they are.
Want a one-page facility brief?
A single-page summary of this facility's registration and recall history for diligence. Not selling it yet — register interest and we'll follow up.